First Time Loading...

Adimmune Corp
TWSE:4142

Watchlist Manager
Adimmune Corp Logo
Adimmune Corp
TWSE:4142
Watchlist
Price: 28.1 TWD -0.53% Market Closed
Updated: May 12, 2024

Intrinsic Value

ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. [ Read More ]

The intrinsic value of one Adimmune Corp stock under the Base Case scenario is 23.55 TWD. Compared to the current market price of 28.1 TWD, Adimmune Corp is Overvalued by 16%.

Key Points:
Intrinsic Value
Base Case
23.55 TWD
Overvaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Adimmune Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Adimmune Corp stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Adimmune Corp

Provide an overview of the primary business activities
of Adimmune Corp.

What unique competitive advantages
does Adimmune Corp hold over its rivals?

What risks and challenges
does Adimmune Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Adimmune Corp.

Provide P/S
for Adimmune Corp.

Provide P/E
for Adimmune Corp.

Provide P/OCF
for Adimmune Corp.

Provide P/FCFE
for Adimmune Corp.

Provide P/B
for Adimmune Corp.

Provide EV/S
for Adimmune Corp.

Provide EV/GP
for Adimmune Corp.

Provide EV/EBITDA
for Adimmune Corp.

Provide EV/EBIT
for Adimmune Corp.

Provide EV/OCF
for Adimmune Corp.

Provide EV/FCFF
for Adimmune Corp.

Provide EV/IC
for Adimmune Corp.

Show me price targets
for Adimmune Corp made by professional analysts.

What are the Revenue projections
for Adimmune Corp?

How accurate were the past Revenue estimates
for Adimmune Corp?

What are the Net Income projections
for Adimmune Corp?

How accurate were the past Net Income estimates
for Adimmune Corp?

What are the EPS projections
for Adimmune Corp?

How accurate were the past EPS estimates
for Adimmune Corp?

What are the EBIT projections
for Adimmune Corp?

How accurate were the past EBIT estimates
for Adimmune Corp?

Compare the revenue forecasts
for Adimmune Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Adimmune Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Adimmune Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Adimmune Corp compared to its peers.

Compare the P/E ratios
of Adimmune Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Adimmune Corp with its peers.

Analyze the financial leverage
of Adimmune Corp compared to its main competitors.

Show all profitability ratios
for Adimmune Corp.

Provide ROE
for Adimmune Corp.

Provide ROA
for Adimmune Corp.

Provide ROIC
for Adimmune Corp.

Provide ROCE
for Adimmune Corp.

Provide Gross Margin
for Adimmune Corp.

Provide Operating Margin
for Adimmune Corp.

Provide Net Margin
for Adimmune Corp.

Provide FCF Margin
for Adimmune Corp.

Show all solvency ratios
for Adimmune Corp.

Provide D/E Ratio
for Adimmune Corp.

Provide D/A Ratio
for Adimmune Corp.

Provide Interest Coverage Ratio
for Adimmune Corp.

Provide Altman Z-Score Ratio
for Adimmune Corp.

Provide Quick Ratio
for Adimmune Corp.

Provide Current Ratio
for Adimmune Corp.

Provide Cash Ratio
for Adimmune Corp.

What is the historical Revenue growth
over the last 5 years for Adimmune Corp?

What is the historical Net Income growth
over the last 5 years for Adimmune Corp?

What is the current Free Cash Flow
of Adimmune Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Adimmune Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Adimmune Corp

Current Assets 4.7B
Cash & Short-Term Investments 2.5B
Receivables 1.3B
Other Current Assets 921.2m
Non-Current Assets 4.8B
Long-Term Investments 133.2m
PP&E 4B
Intangibles 70.5m
Other Non-Current Assets 605m
Current Liabilities 1.8B
Accounts Payable 42.4m
Short-Term Debt 540m
Other Current Liabilities 1.2B
Non-Current Liabilities 2.2B
Long-Term Debt 1.9B
Other Non-Current Liabilities 305m
Efficiency

Earnings Waterfall
Adimmune Corp

Revenue
1.8B TWD
Cost of Revenue
-1.4B TWD
Gross Profit
410.9m TWD
Operating Expenses
-1.1B TWD
Operating Income
-722.7m TWD
Other Expenses
82.9m TWD
Net Income
-639.9m TWD

Free Cash Flow Analysis
Adimmune Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Adimmune Corp's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

33/100
Profitability
Score

Adimmune Corp's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Adimmune Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
49/100
Solvency
Score

Adimmune Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Adimmune Corp

Wall Street analysts forecast Adimmune Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Adimmune Corp is 35 TWD .

Lowest
Price Target
Not Available
Average
Price Target
35 TWD
25% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Adimmune Corp

1M 1M
+6%
6M 6M
-12%
1Y 1Y
-25%
3Y 3Y
-50%
5Y 5Y
+47%
10Y 10Y
-27%
Annual Price Range
28.1
52w Low
25.3
52w High
38.75
Price Metrics
Average Annual Return 26.89%
Standard Deviation of Annual Returns 63.43%
Max Drawdown -67%
Shares Statistics
Market Capitalization 11.8B TWD
Shares Outstanding 421 508 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Adimmune Corp Logo
Adimmune Corp

Country

Taiwan

Industry

Biotechnology

Market Cap

11.8B TWD

Dividend Yield

0%

Description

ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.

Contact

TAICHUNG
TAICHUNG
No.3, Section 1, Tanxing Road, Tanzi District
+886425381220
http://www.adimmune.com.tw

IPO

2010-09-29

Employees

551

Officers

CEO & Chairman
Mr. Chi-Hsien Chan
President, GM & Director
Mr. Chung-Cheng Liu
COO and VP of R&D
Mr. Chin-Chuan Chang
Chief Legal Officer & General Counsel
Mr. Fei Pan
Chief Medical Officer
Dr. Chun Cheng Chen M.B.A., M.D., M.Sc., Ph.D.
Chief Financial Officer
Mr. Yin-Teng Chang
Show More
Director of Administration Center
Ms. Li-Ya Tang
Head of R&D Division
Chih-Hsiang Leng
Vice President of Quality Assurance Department
Mr. Chin-I Chiu
Show Less

See Also

Discover More
What is the Intrinsic Value of one Adimmune Corp stock?

The intrinsic value of one Adimmune Corp stock under the Base Case scenario is 23.55 TWD.

Is Adimmune Corp stock undervalued or overvalued?

Compared to the current market price of 28.1 TWD, Adimmune Corp is Overvalued by 16%.